Several popular peptides can not be compounded by pharmacies for human use because of the latest FDA regulatory improvements. The FDA has moved quite a few of such substances to Category 2 of its Bulk Drug Substances list, citing safety dangers or inadequate data, building them ineligible for compounding.The peptides we outlined above are frequentl… Read More